Quality by Design-based RP-HPLC Method for Estimation of Curcumin in Rat Plasma and Fecal Microbiota Extract-based Solid Self-nano Emulsifying Drug Delivery System.

Leander Corrie, Monica Gulati, Jaskiran Kaur, Ankit Awasthi, Sukriti Vishwas, Arya Kadukkattil Ramanunny, Rubiya Khursheed, Kamal Dua, Dinesh Kumar Chellappan, Sachin Kumar Singh
{"title":"Quality by Design-based RP-HPLC Method for Estimation of Curcumin in Rat Plasma and Fecal Microbiota Extract-based Solid Self-nano Emulsifying Drug Delivery System.","authors":"Leander Corrie,&nbsp;Monica Gulati,&nbsp;Jaskiran Kaur,&nbsp;Ankit Awasthi,&nbsp;Sukriti Vishwas,&nbsp;Arya Kadukkattil Ramanunny,&nbsp;Rubiya Khursheed,&nbsp;Kamal Dua,&nbsp;Dinesh Kumar Chellappan,&nbsp;Sachin Kumar Singh","doi":"10.2174/2589977515666230120140543","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Curcumin (CRM) is known to possess various therapeutic properties, such as anti-inflammatory and antidiabetic properties, and is, therefore, considered to be an effective therapeutic.</p><p><strong>Objective: </strong>A sensitive method for the estimation of CRM in plasma, as well as fecal matter-based solid self-nano emulsifying drug delivery system (S-SNEDDS), has been reported for the first time.</p><p><strong>Methods: </strong>A bioanalytical method was optimized using Box-Behnken Design having 13 runs and 3 responses. The optimized method was developed using methanol and water (70:30 v/v) with a flow rate of 1 mL/min. Quercetin was used as an internal standard. A specificity test was also performed for the developed CRM solid self-nano emulsifying drug delivery system.</p><p><strong>Results: </strong>The retention time of CRM was found to be 14.18 minutes. The developed method was validated and found to be linear in the range of 50-250 ng/mL with an R<sup>2</sup> of 0.999. Accuracy studies indicated that CRM had a percentage recovery of less than 105% and more than 95%, respectively. Precision studies were carried out for inter, intraday, and inter-analyst precision, and the %RSD was found to be less than 2%. The limit of detection (LOD) and limit of quantification (LOQ) were found to be 3.37 ng/mL and 10.23 ng/mL, respectively. Stability studies for shortterm, long term and freeze-thaw cycles showed a %RSD of less than 2%, indicating the stability of CRM in the plasma matrix. Moreover, the blank fecal microbiota extract slurry did not show any peak at the retention time of CRM in a CRM-loaded solid nanoemulsifying drug delivery system containing fecal microbiota extract indicating its specificity.</p><p><strong>Conclusion: </strong>Hence, the developed method can have clinical implications as it helps estimate CRM in blood samples and also provides a simple and sensitive method for the estimation of plant-based flavonoids along with fecal microbiota extract formulations.</p>","PeriodicalId":37008,"journal":{"name":"Current Drug Research Reviews","volume":"15 3","pages":"272-285"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Drug Research Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/2589977515666230120140543","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 3

Abstract

Background: Curcumin (CRM) is known to possess various therapeutic properties, such as anti-inflammatory and antidiabetic properties, and is, therefore, considered to be an effective therapeutic.

Objective: A sensitive method for the estimation of CRM in plasma, as well as fecal matter-based solid self-nano emulsifying drug delivery system (S-SNEDDS), has been reported for the first time.

Methods: A bioanalytical method was optimized using Box-Behnken Design having 13 runs and 3 responses. The optimized method was developed using methanol and water (70:30 v/v) with a flow rate of 1 mL/min. Quercetin was used as an internal standard. A specificity test was also performed for the developed CRM solid self-nano emulsifying drug delivery system.

Results: The retention time of CRM was found to be 14.18 minutes. The developed method was validated and found to be linear in the range of 50-250 ng/mL with an R2 of 0.999. Accuracy studies indicated that CRM had a percentage recovery of less than 105% and more than 95%, respectively. Precision studies were carried out for inter, intraday, and inter-analyst precision, and the %RSD was found to be less than 2%. The limit of detection (LOD) and limit of quantification (LOQ) were found to be 3.37 ng/mL and 10.23 ng/mL, respectively. Stability studies for shortterm, long term and freeze-thaw cycles showed a %RSD of less than 2%, indicating the stability of CRM in the plasma matrix. Moreover, the blank fecal microbiota extract slurry did not show any peak at the retention time of CRM in a CRM-loaded solid nanoemulsifying drug delivery system containing fecal microbiota extract indicating its specificity.

Conclusion: Hence, the developed method can have clinical implications as it helps estimate CRM in blood samples and also provides a simple and sensitive method for the estimation of plant-based flavonoids along with fecal microbiota extract formulations.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于设计的反相高效液相色谱法测定大鼠血浆和粪便微生物群提取物为基础的固体自纳米乳化给药体系中姜黄素的质量。
背景:姜黄素(Curcumin, CRM)被认为具有多种治疗特性,如抗炎和抗糖尿病特性,因此被认为是一种有效的治疗药物。目的:首次报道了一种灵敏的血浆及粪便基固体自纳米乳化给药系统(S-SNEDDS)中CRM的测定方法。方法:采用Box-Behnken设计优化生物分析方法,共13次运行,3次响应。以甲醇和水(70:30 v/v)为溶剂,流速为1 mL/min。槲皮素作为内标。并对所研制的CRM固体自纳米乳化给药系统进行了特异性试验。结果:中药留置时间为14.18 min。结果表明,该方法在50 ~ 250 ng/mL范围内呈线性关系,R2为0.999。准确性研究表明,CRM的回收率分别小于105%和大于95%。精密度研究进行了间,日内和分析师间的精密度,并发现%RSD小于2%。检测限和定量限分别为3.37 ng/mL和10.23 ng/mL。短期、长期和冻融循环的稳定性研究显示,RSD小于2%,表明CRM在血浆基质中的稳定性。此外,在含有粪便微生物群提取物的固体纳米乳化给药系统中,空白粪便微生物群提取物浆液在CRM的保留时间内没有出现任何峰值,表明其特异性。结论:该方法可用于血液样品中黄酮含量的估算,同时也为植物类黄酮及粪便微生物群提取物的估算提供了一种简便、灵敏的方法,具有一定的临床应用价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Current Drug Research Reviews
Current Drug Research Reviews Medicine-Psychiatry and Mental Health
CiteScore
3.70
自引率
0.00%
发文量
38
期刊最新文献
Advances in Human Brain Organoids: Methodological Innovations and Future Directions for Drug Discovery. Advancing Green Chemistry in Antiviral Therapeutics: A Comprehensive Review. Arbutin's Potential in Neuroprotection: A Promising Role in Mitigating Neurodegenerative Diseases. Ralstonia mannitolilytica Infections: A Systematic Review of Case Reports Unveiling Clinical Patterns and Therapeutic Insights. Synergistic Outcomes in Drug Delivery: Exploring Harmonious Architectures of Interpenetrating Polymer Networks.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1